These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 15844718)

  • 1. Insulin-like growth factor binding protein 3 in inflammatory bowel disease.
    Kirman I; Whelan RL; Jain S; Nielsen SE; Seidelin JB; Nielsen OH
    Dig Dis Sci; 2005 Apr; 50(4):780-4. PubMed ID: 15844718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Major surgical trauma induces proteolysis of insulin-like growth factor binding protein-3 in transgenic mice and is associated with a rapid increase in circulating levels of matrix metalloproteinase-9.
    Belizon A; Kirman I; Balik E; Karten M; Jain S; Whelan RL
    Surg Endosc; 2007 Apr; 21(4):653-8. PubMed ID: 17165116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered plasma matrix metalloproteinase-9/tissue inhibitor of matrix [corrected] metalloproteinase-1 concentration during the early postoperative period in patients with colorectal cancer.
    Kirman I; Jain S; Cekic V; Belizon A; Balik E; Sylla P; Arnell T; Forde KA; Whelan RL
    Surg Endosc; 2006 Mar; 20(3):482-6. PubMed ID: 16432654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The IGF system in patients with inflammatory bowel disease treated with prednisolone or infliximab: potential role of the stanniocalcin-2 / PAPP-A / IGFBP-4 axis.
    Hjortebjerg R; Thomsen KL; Agnholt J; Frystyk J
    BMC Gastroenterol; 2019 Jun; 19(1):83. PubMed ID: 31159802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced serum insulin-like growth factor-1 (IGF-1) and IGF-binding protein-3 levels in adults with inflammatory bowel disease.
    Katsanos KH; Tsatsoulis A; Christodoulou D; Challa A; Katsaraki A; Tsianos EV
    Growth Horm IGF Res; 2001 Dec; 11(6):364-7. PubMed ID: 11914023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteolysis of insulin-like growth factor binding proteins by a novel 50-kilodalton metalloproteinase in human pregnancy serum.
    Kübler B; Cowell S; Zapf J; Braulke T
    Endocrinology; 1998 Apr; 139(4):1556-63. PubMed ID: 9528934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measurement of intact insulin-like growth factor-binding protein-3 in human plasma using a ligand immunofunctional assay.
    Lassarre C; Binoux M
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1260-6. PubMed ID: 11238518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteolytic activity degrading insulin-like growth factor-binding protein-2, -3, -4, and -5 in healthy growing and atretic follicles in the pig ovary.
    Besnard N; Pisselet C; Monniaux D; Monget P
    Biol Reprod; 1997 Apr; 56(4):1050-8. PubMed ID: 9096890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IGF-1, IGFBP-3, VEGF and MMP-9 levels and their potential relationship with renal functions in patients with compensatory renal growth.
    Yildiz B; Kural N; Colak O; Ak I; Akcar N
    Clin Physiol Funct Imaging; 2008 Mar; 28(2):107-12. PubMed ID: 18093232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin-like growth factor binding protein-3 proteolysis in children with insulin-dependent diabetes mellitus: a possible role for insulin in the regulation of IGFBP-3 protease activity.
    Bereket A; Lang CH; Blethen SL; Fan J; Frost RA; Wilson TA
    J Clin Endocrinol Metab; 1995 Aug; 80(8):2282-8. PubMed ID: 7543110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteolytic activity is involved in changes in intrafollicular insulin-like growth factor-binding protein levels during growth and atresia of ovine ovarian follicles.
    Besnard N; Pisselet C; Zapf J; Hornebeck W; Monniaux D; Monget P
    Endocrinology; 1996 May; 137(5):1599-607. PubMed ID: 8612491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid increase in serum levels of matrix metalloproteinase-9 (MMP-9) postoperatively is associated with a decrease in the amount of intracellular MMP-9.
    Belizon A; Kirman I; Karten M; Jain S; Whelan RL
    Surg Innov; 2005 Dec; 12(4):333-7. PubMed ID: 16424954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence supporting proteolytic cleavage of insulin-like growth factor binding protein-1 (IGFBP-1) protein in amniotic fluid.
    Lee SE; Han BD; Park IS; Romero R; Yoon BH
    J Perinat Med; 2008; 36(4):316-23. PubMed ID: 18598121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunoassay of insulin-like growth factor-binding protein-3 (IGFBP-3): new means to quantifying IGFBP-3 proteolysis.
    Diamandi A; Mistry J; Krishna RG; Khosravi J
    J Clin Endocrinol Metab; 2000 Jun; 85(6):2327-33. PubMed ID: 10852472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pregnancy-associated plasma protein-A is involved in insulin-like growth factor binding protein-2 (IGFBP-2) proteolytic degradation in bovine and porcine preovulatory follicles: identification of cleavage site and characterization of IGFBP-2 degradation.
    Monget P; Mazerbourg S; Delpuech T; Maurel MC; Manière S; Zapf J; Lalmanach G; Oxvig C; Overgaard MT
    Biol Reprod; 2003 Jan; 68(1):77-86. PubMed ID: 12493698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inflammation-related neutrophil proteases, cathepsin G and elastase, function as insulin-like growth factor binding protein proteases.
    Gibson TL; Cohen P
    Growth Horm IGF Res; 1999 Aug; 9(4):241-53. PubMed ID: 10512690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Open surgery induces a dramatic decrease in circulating intact IGFBP-3 in patients with colorectal cancer not seen with laparoscopic surgery.
    Kirman I; Cekic V; Poltoratskaia N; Sylla P; Jain S; Forde KA; Whelan RL
    Surg Endosc; 2005 Jan; 19(1):55-9. PubMed ID: 15531967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteolytic modification of insulin-like growth factor-binding proteins: comparison of conditioned media from human cell lines, circulating proteases and characterized enzymes.
    Frost VJ; Macaulay VM; Wass JA; Holly JM
    J Endocrinol; 1993 Sep; 138(3):545-54. PubMed ID: 7506292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased bioavailability of insulin-like growth factor-I, a cause of catabolism in hemodialysis patients?
    Lindgren BF; Odar-Cederlöf I; Ericsson F; Brismar K
    Growth Regul; 1996 Sep; 6(3):137-43. PubMed ID: 8894646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary insulin-like growth factors (IGF) and IGF-binding proteins in normal subjects, growth hormone deficiency, and renal disease.
    Gargosky SE; Hasegawa T; Tapanainen P; MacGillivray M; Hasegawa Y; Rosenfeld RG
    J Clin Endocrinol Metab; 1993 Jun; 76(6):1631-7. PubMed ID: 7684745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.